Printing and Packaging Personal care Government and Military Corporate/Financial News Security and asset marking Pharmaceuticals COVID-19
Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
September 20, 2018
APDN Executes New 2 Year Contract with the U.S. Defense Logistics Agency
September 11, 2018
Applied DNA Announces $1.65 Million Private Placement of Secured Convertible Notes
September 4, 2018
APDN Presenting Linear DNA for Gene Therapy at Boston Immuno-Oncology Summit
August 27, 2018
Applied DNA Schedules Fiscal 2018 Third Quarter Financial Results Conference Call for Monday, August 13, 2018 at 4:30 PM ET
August 6, 2018
Get Social